Alterity Therapeutics Ltd ATHE

NAS: ATHE | ISIN: US02155X1063   1/05/2025
3,450 USD (-0,29%)
(-0,29%)   1/05/2025

31 januari 2023 · Appendix 4C - Q2 FY23 Quarterly Cash Flow Report · Persbericht

9 januari 2023 · Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy · Persbericht

6 januari 2023 · Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) · Persbericht

3 januari 2023 · Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum · Persbericht

29 december 2022 · Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office · Persbericht

7 november 2022 · Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting · Persbericht

28 oktober 2022 · Appendix 4C - Q1 FY23 Quarterly Cash Flow Report · Persbericht

26 oktober 2022 · Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting · Persbericht

13 oktober 2022 · Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy · Persbericht

26 september 2022 · Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease and Movement Disorders · Persbericht

20 september 2022 · Alterity Therapeutics Receives U.S. FDA Approval for Investigational New Drug Application for ATH434 for the Treatment of Multiple System Atrophy · Persbericht

25 augustus 2022 · Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy in Europe · Persbericht

22 juli 2022 · Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report · Persbericht

Mijn selecties